Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Visit
iwCAR-T 2024
The 6th International Workshop on CAR-T & Immunotherapies
19–21 April 2024 | Miami, FL
Expert-led presentations and roundtable discussions from iwCAR-T 2024, covering CAR-T and immunotherapies for solid tumors.
Review of results from CAR-T and TCRs in solid tumors
Julian Molina Mayo Clinic, Rochester, MN
Head & neck and brain tumors
Updates in cellular immunotherapy for head & neck cancers
Kedar Kirtane H. Lee Moffitt Cancer Center & Research Institute
ALK-CAR T-cells for relapsed/refractory neuroblastoma
Susanne Baumeister Boston Children's Hospital
CAR-T clinical advances in lung cancer
Updates on TIL therapy in lung cancer
Ben Creelan Moffitt Cancer Center
Tumor immune modulation in solid tumor CAR T-cell therapy
Prasad Adusumilli Memorial Sloan Kettering Cancer Center, New York City, NY
LL3-directed CAR T-cells in small cell lung cancer
Adam Schoenfeld Memorial Sloan Kettering Cancer Center
Breast and ovarian cancers
LYL797 in adults with solid tumors
Jennifer Specht Seattle Cancer Care Alliance, University of Washington, Seattle, WA
TCR-based therapeutics that target ‘public neoantigens’
Smita Chandran Memorial Sloan Kettering Cancer Center
Intratumoral delivery of dendritic cell-based immunotherapies
Saurabh Garg Moffitt Cancer Center
Engineering NK cells for ovarian cancer
Rizwan Romee Dana-Farber Cancer Institute
Melanoma and sarcomas
Autologous tumor infiltrating lymphocytes for metastatic melanoma (LN-144)
Amod Sarnaik Moffitt Cancer Center
TIL therapy for melanoma – have we reached the tip of the Iceberg?
Allison Betof Warner Stanford Medicine
Afami-cel in advanced synovial sarcoma and myxoid/round cell liposarcoma
Elizabeth Loggers Fred Hutchinson Cancer Center
Logistics and manufacturing
Manufacturing/FACT and ASTCT 80/20
Sarah Nikiforow Dana-Farber Cancer Institute
Gastrointestinal cancers
CAR-T advances in pancreatic cancer
Diane Simeone NYU Langone Health, New York City, NY
Autologous TAC T-cells targeting solid tumors, HER2 and Claudin18.2
Benjamin Schlechter Dana-Farber Cancer Institute
T-cell therapy of GI tumors
Joel Randolph Hecht UCLA Health, Los Angeles
Genitourinary cancers
Bispecific antibodies and CAR-T approaches in mCRPC
Vivek Narayan University of Pennsylvania, Philadelphia, PA
Advancing engineered T-cell therapies for solid tumors
Saul Priceman City of Hope Medical Center
TILs treatment in bladder cancers
Michael Poch Moffitt Cancer Center
iwCAR-T 2024 was supported by:
